Cwm, LLC Pacira Bio Sciences, Inc. Transaction History

Cwm, LLC

$23.3 Billion
Q3 2024

A detailed history of Cwm, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Cwm, LLC holds 6,517 shares of PCRX stock, worth $128,775. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,517

Previous 801 713.61%

Holding current value

$128,775

Previous $23,000 326.09%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$11.7 - $28.46 $66,877 - $162,677	5,716 Added 713.61%	6,517 $98,000
Q2 2024 Jul 09, 2024	SELL	$25.5 - $31.51 $306 - $378	-12 Reduced 1.48%	801 $23,000
Q1 2024 Apr 05, 2024	BUY	$27.7 - $35.48 $1,412 - $1,809	51 Added 6.69%	813 $24,000
Q4 2023 Feb 01, 2024	SELL	$26.32 - $34.31 $526 - $686	-20 Reduced 2.56%	762 $26,000
Q3 2023 Oct 11, 2023	SELL	$30.68 - $40.09 $20,616 - $26,940	-672 Reduced 46.22%	782 $24,000
Q2 2023 Aug 03, 2023	BUY	$36.12 - $47.5 $1,119 - $1,472	31 Added 2.18%	1,454 $58,000
Q1 2023 Apr 28, 2023	BUY	$35.53 - $43.38 $34,819 - $42,512	980 Added 221.22%	1,423 $58,000
Q4 2022 Feb 01, 2023	BUY	$38.19 - $57.45 $572 - $861	15 Added 3.5%	443 $17,000
Q3 2022 Oct 27, 2022	BUY	$51.24 - $58.89 $5,124 - $5,889	100 Added 30.49%	428 $23,000
Q2 2022 Jul 28, 2022	SELL	$51.49 - $81.64 $875 - $1,387	-17 Reduced 4.93%	328 $19,000
Q1 2022 Apr 21, 2022	BUY	$60.03 - $76.49 $1,800 - $2,294	30 Added 9.52%	345 $26,000
Q4 2021 Jan 31, 2022	SELL	$47.97 - $62.21 $1,678 - $2,177	-35 Reduced 10.0%	315 $19,000
Q2 2019 Jul 31, 2019	BUY	$36.57 - $47.97 $12,799 - $16,789	350 New	350 $15,000
Q1 2019 Apr 22, 2019	SELL	$36.47 - $42.17 $328 - $379	-9 Closed	0 $0
Q4 2018 Jan 25, 2019	BUY	$41.31 - $52.16 $371 - $469	9 New	9 $0

Others Institutions Holding PCRX

# of Institutions

264

Shares Held

50.6M

Call Options Held

429K

Put Options Held

391K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $905M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account